Millions of Medicare Advantage enrollees who end up in hospitals no longer face the risk of having their approved stays pulled out from under them. Under the 2024 Medicare Advantage and Part D Final Rule, known as CMS-4201-F, a prior-authorization approval for a course of treatment must remain valid for as long as the care is medically reasonable and necessary. The regulation, codified at 42 CFR 422.138, bars Medicare Advantage organizations from revoking coverage on medical-necessity grounds after they have already approved an inpatient admission or concurrent determination. The practical result: once a plan says yes, it cannot reverse that decision while the patient is still in the hospital bed.
High overturn rates exposed a broken denial system
The rule did not appear in a vacuum. Federal watchdog data collected in June 2024 showed that Medicare Advantage organizations routinely denied post-acute care requests and then reversed those same denials when patients or providers appealed. Across 19 Medicare Advantage organizations studied by the HHS Office of Inspector General, plans overturned 36% of long-term acute care hospital denials on appeal. For inpatient rehabilitation facility requests, the overturn rate reached 43%, suggesting that a substantial share of initial denials did not hold up under closer review.
Skilled nursing facility admissions told an even starker story. A companion OIG report found that Medicare Advantage organizations reversed 95% of appealed SNF denials in June 2024. The contractor naviHealth processed a share of those SNF prior-authorization requests on behalf of multiple plans, inserting another layer between hospitals seeking to discharge patients and the facilities prepared to receive them. When nearly all appealed denials end up overturned, the initial denial functions less as a clinical judgment and more as an administrative barrier that delays discharge and placement.
These patterns were not new. A 2022 OIG review had already documented that some Medicare Advantage organizations denied prior authorization for services that met Medicare coverage rules, raising direct concerns about beneficiary access to medically necessary care. Together, those findings painted a picture of a system in which plans could use prior authorization not just to manage utilization, but to erect hurdles that discouraged or slowed access to covered services.
What the CMS rule actually requires of plans
The final rule, as described in the CMS explanatory materials, states that prior-authorization approval for a course of treatment must remain in effect to avoid disruptions in care. The regulatory text at 42 CFR 422.138 requires Medicare Advantage organizations to honor an initial authorization for the full course of treatment, so long as the service continues to be medically reasonable and necessary and remains consistent with the original approval.
In practical terms, this means that once a plan authorizes an inpatient hospital stay, it cannot later declare that same stay not medically necessary simply because a utilization review nurse or algorithm reaches a different conclusion mid-course. Plans may still conduct concurrent review to coordinate care, plan for discharge, or identify post-acute needs, but they cannot use that process to retroactively revoke coverage for days already approved within the authorized episode.
The rule also clarifies that plans must apply coverage criteria that are no more restrictive than Traditional Medicare when making prior-authorization decisions. If Medicare would cover an inpatient admission or a post-acute stay under its own rules, a Medicare Advantage plan cannot deny or truncate that care based on proprietary guidelines that conflict with Medicare standards. This alignment requirement is designed to prevent plans from quietly tightening access through internal policies while still marketing themselves as offering the same benefits as Medicare.
Implications for hospitals, post-acute providers, and patients
For hospitals, the new protections reduce the risk that an authorized admission will later be labeled “not medically necessary” after discharge, leaving facilities and patients to fight over unpaid bills. Clinicians can focus more on clinical criteria for admission and continued stay, rather than anticipating how a plan might reinterpret its own authorization decision days later. Revenue-cycle teams, in turn, gain more predictability about which claims should be payable once an authorization is in hand.
Post-acute providers may also see smoother transitions. When a hospital knows that the inpatient portion of a patient’s stay is secure, discharge planning for long-term acute care, inpatient rehabilitation, or skilled nursing can proceed without the shadow of a potential retroactive denial. That does not eliminate prior authorization for post-acute levels of care, but it narrows the circumstances in which a patient’s trajectory can be disrupted by shifting coverage determinations.
For beneficiaries and families, the most immediate benefit is reduced uncertainty. A prior-authorization approval now carries a stronger guarantee that coverage will remain intact for the full course of treatment, absent a genuine change in medical necessity. While patients still retain appeal rights if a plan denies or limits subsequent services, they are less likely to face surprise reversals for care that had already been greenlighted.
The new rule does not end all disputes over medical necessity, nor does it eliminate prior authorization in Medicare Advantage. It does, however, close a loophole that allowed plans to approve hospital care at the front end and then undermine that same approval after the patient was already receiving treatment. By requiring continuity of authorization and closer alignment with Medicare coverage rules, CMS aims to shift prior authorization back toward its stated purpose: ensuring that care is appropriate, not erecting barriers to care that Medicare itself would cover.
